Malashkevich V N, Strop P, Keller J W, Jansonius J N, Toney M D
Department of Structural Biology, Biozentrum University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland.
J Mol Biol. 1999 Nov 19;294(1):193-200. doi: 10.1006/jmbi.1999.3254.
The crystal structures of four inhibitor complexes of dialkylglycine decarboxylase are reported. The enzyme does not undergo a domain closure, as does aspartate aminotransferase, upon inhibitor binding. Two active-site conformations have been observed in previous structures that differ in alkali metal ion content, and two active-site conformations have been shown to coexist in solution when a single type of metal ion is present. There is no indication of coexisting conformers in the structures reported here or in the previously reported structures, and the observed conformation is that expected based on the presence of potassium in the enzyme. Thus, although two active-site conformations coexist in solution, a single conformation, corresponding to the more active enzyme, predominates in the crystal. The structure of 1-aminocyclopropane-1-carboxylate bound in the active site shows the aldimine double bond to the pyridoxal phosphate cofactor to be fully out of the plane of the coenzyme ring, whereas the Calpha-CO2(-) bond lies close to it. This provides an explanation for the observed lack of decarboxylation reactivity with this amino acid. The carboxylate groups of both 1-aminocyclopropane-1-carboxylate and 5'-phosphopyridoxyl-2-methylalanine interact with Ser215 and Arg406 as previously proposed. This demonstrates structurally that alternative binding modes, which constitute substrate inhibition, occur in the decarboxylation half-reaction. The structures of d and l-cycloserine bound to the active-site show that the l-isomer is deprotonated at C(alpha), presumably by Lys272, while the d-isomer is not. This difference explains the approximately 3000-fold greater potency of the l versus the d-isomer as a competitive inhibitor of dialkylglycine decarboxylase.
报道了二烷基甘氨酸脱羧酶四种抑制剂复合物的晶体结构。与天冬氨酸转氨酶不同,该酶在结合抑制剂后不会发生结构域闭合。在先前的结构中观察到两种活性位点构象,它们在碱金属离子含量上有所不同,并且当存在单一类型的金属离子时,已证明两种活性位点构象共存于溶液中。在此报道的结构或先前报道的结构中均未显示共存构象体的迹象,并且观察到的构象是基于酶中钾的存在所预期的构象。因此,尽管两种活性位点构象共存于溶液中,但对应于活性更高的酶的单一构象在晶体中占主导地位。结合在活性位点的1-氨基环丙烷-1-羧酸盐的结构表明,与磷酸吡哆醛辅因子的醛亚胺双键完全不在辅酶环平面内,而α-羧基(-)键则与之接近。这为观察到的该氨基酸缺乏脱羧反应活性提供了解释。如先前提出的那样,1-氨基环丙烷-1-羧酸盐和5'-磷酸吡哆醛-2-甲基丙氨酸的羧基均与Ser215和Arg406相互作用。这在结构上证明了在脱羧半反应中存在构成底物抑制的替代结合模式。结合到活性位点的d-和l-环丝氨酸的结构表明,l-异构体在α-碳处去质子化,可能是由Lys272导致的,而d-异构体则没有。这种差异解释了l-异构体作为二烷基甘氨酸脱羧酶竞争性抑制剂的效力比d-异构体大约高3000倍的原因。